Jacob Pawloski

Dr. Jacob Pawloski

Henry Ford Hospital

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JPJacob Pawloski
Jacob Pawloski
HFHassan A. Fadel
Hassan A. Fadel
YHYi-Wen Huang
Yi-Wen Huang
ILIan Lee
Ian Lee
Meningiomas represent a phenotypically and genetically diverse group of tumors which often behave in ways that are not simply explained by their pathologic grade. The genetic landscape of meningiomas has become a target of investigation as tumor genomics have been found to impact tumor location, recurrence risk, and malignant potential. Additionally, targeted therapies are being developed that in the future may provide patients with personalized chemotherapy based on the genetic aberrations within their tumor. This review focuses on the most common genetic mutations found in meningiomas of all grades, with an emphasis on the impact on tumor location and clinically relevant tumor characteristics. NF-2 and the non-NF-2 family of genetic mutations are summarized in the context of low-grade and high-grade tumors, followed by a comprehensive discussion regarding the genetic and embryologic basis for meningioma location and phenotypic heterogeneity. Finally, targeted therapies based on tumor genomics currently in use and under investigation are reviewed and future avenues for research are suggested. The field of meningioma genomics has broad implications on the way meningiomas will be treated in the future, and is gradually shifting the way clinicians approach this diverse group of tumors.

16 April 2020 in Current Oncology Reports
Verified
Journal Article
Closed access
PDF file
JSJames M. Snyder
James M. Snyder
JPJacob Pawloski
Jacob Pawloski
LPLaila Poisson
Laila Poisson

19 January 2024 in Journal of Neuro-Oncology
Verified
Journal Article
Open access
PDF file
JRJared C. Reese
Jared C. Reese
HFHassan A. Fadel
Hassan A. Fadel
JPJacob Pawloski
Jacob Pawloski
MSMariam Samir
Mariam Samir
SHSameah Haider
Sameah Haider
ILIan Lee
Ian Lee
Purpose Laser interstitial thermal therapy (LITT) is a minimally invasive cytoreductive treatment option for brain tumors with a risk of vascular injury from catheter placement or thermal energy. This may be of concern with deep-seated tumors that have surrounding end-artery perforators and critical microvasculature. The purpose of this study was to assess the risk of distal ischemia following LITT for deep-seated perivascular brain tumors. Methods A retrospective review of a multi-institution database was used to identify patients who underwent LITT between 2013 and 2022 for tumors located within the insula, thalamus, basal ganglia, and anterior perforated substance. Demographic, clinical and volumetric tumor characteristics were collected. The primary outcome was radiographic evidence of distal ischemia on post-ablation magnetic resonance imaging (MRI). Results 61 LITT ablations for deep-seated perivascular brain tumors were performed. Of the tumors treated, 24 (39%) were low-grade gliomas, 32 (52%) were high-grade gliomas, and 5 (8%) were metastatic. The principal location included 31 (51%) insular, 14 (23%) thalamic, 13 (21%) basal ganglia, and 3 (5%) anterior perforated substance tumors. The average tumor size was 19.6 cm3 with a mean ablation volume of 11.1 cm3. The median extent of ablation was 92% (IQR 30%, 100%). Two patients developed symptomatic intracerebral hemorrhage after LITT. No patient had radiographic evidence of distal ischemia on post-operative diffusion weighted imaging. Conclusion We demonstrate that LITT for deep-seated perivascular brain tumors has minimal ischemic risks and is a feasible cytoreductive treatment option for otherwise difficult to access intracranial tumors.

8 July 2021 in Spine
Verified
Journal Article
Closed access
SLSeokchun Lim
Seokchun Lim
MBMichael Bazydlo
Michael Bazydlo
MMMohamed Macki
Mohamed Macki
SHSameah Haider
Sameah Haider
LSLonni Schultz
Lonni Schultz
VCVictor Chang
Victor Chang
Study Design.: This is a retrospective, cohort analysis of multi-institutional database. Objective.: This study was designed to analyze the impact of drain use following elective anterior cervical discectomy and fusion (ACDF) surgeries. Summary of Background Data.: After ACDF, a drain is often placed to prevent postoperative hematoma. However, there has been no high quality evidence to support its use with ACDF despite the theoretical benefits and risks of drain placement. Methods.: The Michigan Spine Surgery Improvement Collaborative database was queried to identify all patients undergoing elective ACDF between February 2014 and October 2019. Cases were divided into two cohorts based on drain use. Propensity-score matching was utilized to adjust for inherent differences between the two cohorts. Measured outcomes included surgical site hematoma, length of stay, surgical site infection, dysphagia, home discharge, readmission within 30 days, and unplanned reoperation. Results.: We identified 7943 patients during the study period. Propensity-score matching yielded 3206 pairs. On univariate analysis of matched cohorts, there were no differences in rate of postoperative hematoma requiring either return to OR or readmission. We noted patients with drains had a higher rate of dysphagia (4.6% vs. 6.3%; P = 0.003) and had longer hospital stay (P < 0.001). On multivariate analysis, drain use was associated with significantly increased length of stay (relative risk 1.23, 95% confidence interval [CI] 1.13–1.34; P < 0.001). There were no significant differences in other outcomes measured. Conclusion.: Our analysis demonstrated that drain use is associated with significant longer hospital stay. Level of Evidence: 3

14 February 2023 in World Neurosurgery
Verified
Journal Article
Closed access
SLSeokchun Lim
Seokchun Lim
LSLonni Schultz
Lonni Schultz
PZPhilip Zakko
Philip Zakko
MMMohamed Macki
Mohamed Macki
THTravis Hamilton
Travis Hamilton
VCVictor Chang
Victor Chang

26 February 2024 in Journal of Neurosurgery: Case Lessons
Verified
Journal Article
Open access
PDF file
AMAlexis Malecki
Alexis Malecki
JPJacob Pawloski
Jacob Pawloski
AAAnthony Anzalone
Anthony Anzalone
KSKelly Shaftel
Kelly Shaftel
HFHassan Ali Fadel
Hassan Ali Fadel
ILIan Lee
Ian Lee
BACKGROUND: Diffuse spinal dural calcification is a rare disorder associated with hyperparathyroidism, including the secondary forms associated with renal failure, osteodystrophy, and chronic hypocalcemia. Here, the authors report a rare case of diffuse dural calcification causing spinal cord compression with myelopathy, requiring decompressive surgery with duraplasty to achieve adequate decompression. OBSERVATIONS: A 46-year-old male with a history of renal failure on dialysis presented with 2 months of progressive neuropathic pain, lower-extremity weakness, and nonsustained clonus. Spine imaging showed severe renal osteodystrophy with multilevel compression fractures and diffuse dural calcifications with areas of invagination causing severe spinal cord compression. Decompressive surgery was recommended. In surgery, a thickened and calcified dura was encountered with areas of buckling causing spinal cord compression. The invaginated area of the dura was resected and reconstructed with patch duraplasty. The patient’s neurological status remained unchanged postoperatively, and at the 6-month follow-up, the patient reported significant improvement in pain and muscle spasms. LESSONS: Diffuse dural calcifications are a rare complication of prolonged dialysis and secondary hyperparathyroidism. When there is resultant spinal cord compression, this condition requires an intradural approach that addresses the thickened, calcified dura directly to obtain adequate spinal cord decompression.